COVID-19 Vaccine
Cellid Co.,Ltd. leads research of anti-cancer immunotherapies and Vaccines for preventing infectious diseases
Technical Competitivity
EES Effectively induce neutralizing antibody and cytotoxic T cell production
Cellid's COVID-19 spike protein design considered elevating structural stability and expression rate.
This gives immune cells enough time to recognize antigens, and as a result, it induces effective antibody production and durable CD8 T cell responses.
Scroll left and right to read.
